vettinsider

One Profession, Many Frontiers: A Global, Human, and Data-Smart View of Veterinary Practice 5Ed.

Discover veterinary frontiers in 2025: AI with 95% diagnostic accuracy, new antimicrobial drugs, global telemedicine, and compelling clinical cases.

Admin 2025-11-26

One Profession, Many Frontiers: A Global, Human, and Data-Smart View of Veterinary Practice 5Ed.

Veterinary medicine has never been more interconnected, more innovative, or more essential to global health. From remote villages in Nepal where veterinarians vaccinate street dogs against rabies, to cutting-edge AI laboratories developing personalized cancer treatments for companion animals, to humanitarian missions bringing veterinary care to communities devastated by natural disasters our profession operates on countless frontiers simultaneously.

This edition of vettINSIDER celebrates the diversity and depth of modern veterinary medicine through five distinct perspectives: Global Veterinary Outreach showcasing humanitarian work worldwide, Technology & Innovation Frontier highlighting breakthrough tools transforming practice, Pharmaceutical Advances presenting the latest medications and alternatives, Clinical Case Spotlight examining a fascinating diagnostic challenge, and The Human Element exploring the compassionate relationships that define our calling.

The veterinary profession is vast. These are its many frontiers.

SECTION 1: Global Veterinary Outreach

The World Veterinary Association's 2025-2030 Vision: Unifying 7 Million Veterinarians

The World Veterinary Association (WVA) launched its forward-looking 2025-2030 Strategic Plan in September 2025, reaffirming its mission to strengthen the global veterinary profession and deliver tangible value to members worldwide. As a federation of national, regional, and specialty veterinary associations, the WVA recognizes the increasing need for international alignment in veterinary medicine, particularly in disease control, food safety, animal welfare, medicines availability, and the ecological impact of health systems.

At the heart of WVA's work lies the One Health approach, promoting the interconnected health of humans, animals, and the environment. Through partnerships with WHO, FAO, WOAH (formerly OIE), and UNEP collectively known as the Quadripartite the WVA leads global advocacy, support, and education initiatives that shape the future of veterinary medicine.

The Four Strategic Pillars (2025-2030)

Animal Welfare: Advancing standards and protocols that ensure humane treatment across all species and production systems

Medicines Stewardship: Addressing antimicrobial resistance through responsible prescribing, alternatives development, and global surveillance

One Health Integration: Strengthening the veterinary profession's central role in zoonotic disease prevention, pandemic preparedness, and environmental health

Veterinary Profession & Education: Supporting workforce development, educational standards, and professional recognition globally

What distinguishes this strategy is its dynamic framework: each five-year strategic goal is supported by 1-2 year action plans, reviewed annually by the WVA Council to maintain progress, adaptability, and impact. This agile approach allows the association to respond rapidly to emerging threats while maintaining long-term vision.

World Veterinary Day 2025: "Animal Health Takes a Team"

The WVA announced "Animal Health Takes a Team" as the theme for World Veterinary Day 2025, highlighting the collaborative nature of veterinary practice and underscoring the essential role that multiple professionals play in delivering high-quality veterinary services.

This theme focuses on the importance of teamwork in veterinary care, acknowledging that effective veterinary services often rely on the collective efforts of veterinary nurses, technicians, researchers, and allied health professionals. The WVA Council selected this theme to shine a spotlight on the dynamic nature of veterinary services, which require cooperation and collaboration across various fields of expertise to address diverse challenges in animal health and care.

Veterinary Humanitarian Missions: Boots on the Ground Worldwide

International Veterinary Outreach (IVO) has operated since 2011, providing veterinary care while training veterinary professionals in economically-disadvantaged communities worldwide. Their One Health approach to sustainable veterinary services extends across continents: from Jiquilillo, Nicaragua, to Annapurna, Nepal, to Dodoma, Tanzania.

IVO's proudest achievements come from helping underprivileged communities: training new veterinarians, helping animals in need, and conducting global health research where it's needed most. Their current Nepal deployment uses a collective and cross-sectoral approach to ensure sustained positive impacts on regional health, welfare, and conservation efforts, particularly focusing on working animals.

World Vets operates multiple international field service projects throughout the year, with volunteer opportunities for veterinarians, veterinary technicians, students and assistants. Their projects encompass small and large animal work, equine welfare, surgical instruction and training across multiple continents.

Worldwide Veterinary Service (WVS) transforms compassion into adventure with purpose. Whether helping to vaccinate dogs against rabies, assisting in wildlife rehabilitation, or training local vets in life-saving techniques, volunteers make a world of difference. Their projects span from bustling cities to remote communities, with roles for everyone from experienced veterinarians to passionate animal lovers.

The Biothreat Conference: Veterinarians as Frontline Defense

WOAH hosted the Global Conference on Biological Threat Reduction on October 28-30, 2025 in Geneva, Switzerland, bringing together experts from security, human health, animal health, and environmental sectors to discuss rising security risks and strategies to bridge the biological threat reduction gap.

The data paint a staggering picture: over 75% of emerging diseases and 80% of agents with bioterrorist potential are zoonotic in nature, making animal health a key pillar of global health security. Other figures show that production animals account for 40% of global agriculture value, and nearly 1 in 5 people depend on production animals for their income.

Dr. Emmanuelle Soubeyran, Director General at WOAH, emphasized: "In our increasingly connected and complex world, global health security is also a matter of national security, which makes veterinarians the frontline of defense. Yet, protecting against biological threats requires united action across sectors".

The Pandemic Fund, launched in November 2022 during the G20 Conference, already received over $1.4 billion in financial commitments. WOAH acts as an observer at the Pandemic Fund board while providing continuous technical support to Veterinary Services and fostering collaborative actions to submit joint proposals.

SECTION 2: Technology & Innovation Frontier

AI-Powered Diagnostics Achieving 95% Accuracy

By 2025, AI in veterinary medicine is projected to grow at a CAGR of over 30% through 2030, reaching an estimated $1.5 billion market value. This surge underscores AI's critical role in future-proofing veterinary practices worldwide.

AI-driven diagnostic tools now analyze radiographs, ultrasounds, and pathology slides with up to 95% accuracy, outperforming traditional methods in some studies. For example, AI-based image analysis platforms detect subtle bone fractures or early tumor development in equine and canine patients, speeding diagnosis and enabling earlier interventions.

Vetology's AI Virtual Radiologist

Vetology's AI diagnostic engine processes radiographic images through multiple analytical layers, simultaneously evaluating anatomical structures, detecting abnormalities, and generating detailed clinical reports within minutes. The platform integrates with existing practice management systems, enabling seamless workflow integration.

The system's AI extends beyond basic image analysis, incorporating specialized algorithms for automated cardiac measurements and vertebral heart scoring. This technical foundation enables the platform to process multiple imaging modalities, achieving a 92% agreement rate with board-certified radiologists through its advanced pattern recognition capabilities.

Zoetis Vetscan OptiCell: First AI-Powered Hematology Analyzer

Zoetis expanded availability of its advanced point-of-care veterinary hematology analyzer into Europe in September 2025. The Vetscan OptiCell is the first cartridge-based diagnostic tool powered by artificial intelligence and is now available across the US, UK, Australia, and Europe.

"With Vetscan OptiCell and the innovation behind it we are supporting veterinary teams to elevate patient care, enhance clinical decision-making, and drive value in practice," said Abhay Nayak, President of Global Diagnostics at Zoetis. The tool provides fast and accurate complete blood count analysis, addressing the rapid increase in demand for veterinary care in recent years.

Rayvision's 4-in-1 Diagnostic Revolution

Rayvision Medical Limited debuted its groundbreaking 4-in-1 veterinary diagnostic device at the 2025 London Vet Show in October. The integrated device combines dynamic and static DR (Digital Radiography), CT, and dental diagnostics, plus innovative animal respiratory stabilization to reduce image artifacts and DSA high-definition vascular imaging.

This innovation addresses small and medium veterinary clinics' pain points of high multi-device costs and cumbersome workflows while offering customization. Rayvision has been deeply engaged in the CBCT field for over 10 years, holding numerous patents and providing customized products with comprehensive support for maintenance, servicing, and image interpretation.

Standing Cross-Sectional Imaging: Revolutionizing Equine Care

The development of CT and MRI units that enable limb scans in standing animals has revolutionized the accessibility and ease of imaging for equine patients. Negating the need for general anaesthesia, the ability to obtain advanced images of complex structures particularly in the foot without anaesthesia as an outpatient procedure has vastly improved lameness diagnosis for large animal patients.

Mars Petcare's RenalTech: AI Predicting Feline Kidney Disease

RenalTech is a proprietary Mars Petcare technology using AI in the early detection of feline chronic kidney disease (CKD). Created with a dataset drawing on the medical records of hundreds of thousands of cats, the system analyzes blood and urine data of cats before and after CKD diagnosis.

The result is a tool that can help predict whether a cat will develop CKD within two years, enabling early intervention before clinical symptoms appear. This represents the power of AI's predictive capabilities to personalize patient treatment and improve the chances of successful outcomes.

ImpriMed: Personalized Oncology for Canine Lymphoma

Machine learning algorithms and live cancer cell analysis are being used to predict the efficacy of anticancer drugs for lymphoma in individual dogs. Dr. Joseph Impellizeri explained that the traditional treatment protocol for lymphoma (CHOP) uses a mix of chemotherapies but doesn't account for the individuality of each patient, and patient response varies significantly.

ImpriMed, a California-based startup, offers a personalized treatment protocol that uses AI to predict the efficacy of more than a dozen drugs commonly used to treat canine lymphoma. "There is clearly a need for more personalized medicine and the ability to assess whether or not a lymphoma has a better chance to be responsive to a certain drug would be very helpful," Dr. Impellizeri emphasized.

Generative AI Transforming Drug Discovery

Zoetis scientists harnessed Generative AI (GenAI) and advanced technologies in 2024 aimed at accelerating the timeline from discovery to launch for critical medicines and vaccines. Their GenAI platform integrates vast biodata into interactive knowledge graphs, helping scientists uncover insights into disease pathology, biomarkers and drug targets faster such as those involved in chronic kidney disease affecting pets.

Zoetis scientists leverage data from over 20,000 early research and clinical studies, pet genetics through Basepaws and other sources a daunting task without AI. In 2024, they launched the Automation and Data Sciences group to apply advanced technologies, automate R&D processes and generate data-driven insights to accelerate decision-making.

Looking ahead, Zoetis scientists will pilot an AI-powered clinical data management system in 2025 to make scientific data review and validation considerably faster and more efficient. Another GenAI-powered project aims to significantly reduce the time needed to write regulatory submissions and scientific publications.

SECTION 3: Pharmaceutical Advances

FDA Approvals & Safety Updates: October 2025

The FDA's Center for Veterinary Medicine updated its Recent Animal Drug Approvals page in October 2025 to reflect several significant new products and safety-related labeling changes:

New Approvals

Mometamax Single™ (gentamicin, posaconazole, and mometasone furoate otic suspension) for dogs - Approved April 29, 2025, for treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius and Pseudomonas aeruginosa)

Deletion of Exon 7 of CD163 Gene in Domestic Pigs - Groundbreaking approval April 29, 2025. This genetic modification is intended to confer resistance to porcine reproductive and respiratory syndrome virus (PRRSV) in homozygous pigs. Pigs carrying one or two copies of CD163 ∆E7, and their offspring, are intended for breeding or to be used as sources of food.

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) - Approved May 21, 2025, with addition of indication for treatment and control of hookworm infections in dogs and puppies 8 weeks of age and older, weighing 3.3 pounds or greater

First Generic Gamithromycin Injectable - Approved August 28, 2025, for treatment and control of bovine respiratory disease in beef and non-lactating dairy cattle

First Drug for New World Screwworm - Conditionally approved September 30, 2025, for prevention and treatment of New World Screwworm infestations in cattle

Safety-Related Labeling Changes

Recent safety-related labeling changes were implemented for Stelfonta (tigilanol tiglate injection), Credelio Cat (lotilaner), Galliprant (grapiprant tablets), BRAVECTO 1-MONTH (fluralaner), and Synotic (fluocinolone acetonide and dimethyl sulfoxide).

The 25 Global Actions by 2025: Reducing Antibiotic Need

AnimalhealthEurope members joined a multi-billion euro pledge supporting HealthforAnimals' global "25 Global Actions by 2025" initiative to reduce the need for antibiotics in animals. The pledge sets out three approaches: disease prevention and control, earlier detection of illness, and fast, accurate treatment.

Roxane Feller, AnimalhealthEurope Secretary General, commented: "In Europe coordinated efforts on awareness-raising around antibiotic resistance, and improving disease prevention and animal health management have made notable progress in reducing the need to use antibiotics in animals. Our pledge for further targeted actions will serve to boost such efforts at a global level".

Alternatives to Antimicrobials: The New Frontier

The constant market demand for cheap food of animal origin necessitates finding alternatives to antimicrobials. The alarming data on drug resistance in bacteria isolated from humans and animals indicate a possible risk of a return to the preantibiotic era.

Promising Alternative Approaches

Bacteriophages: Viruses that specifically target and kill bacteria without harming beneficial microbiota or causing resistance at the same rate as traditional antibiotics

Antimicrobial Peptides: Natural defense molecules with broad-spectrum activity and lower resistance development potential

Vaccines: Noteworthy developments including mRNA vaccines, viral vector vaccines (like ChAdOx1 RVF vaccine for Rift Valley fever), and DNA vaccines promise enhanced effectiveness

Immune Modulators: Substances that enhance innate and adaptive immune responses, reducing infection susceptibility without direct antimicrobial action

Microbiome Modulation: Promoting beneficial bacterial populations to competitively exclude pathogens and enhance overall health

Novel Antibiotic Mechanisms for Biodefense

A comprehensive review published in August 2025 identified several promising antibiotics that could broaden the biodefense arsenal:

Gepotidacin - The first-in-class novel bacterial topoisomerase inhibitor, recently FDA-approved for urinary tract infections, effective in nonhuman primate models of plague and tularemia

Omadacycline - A next-generation tetracycline with strong results against plague and anthrax, including resistant strains

BWC0977 (Bugworks) - An oxazolidinone scaffold targeting bacterial DNA gyrase and topoisomerase at a site distinct from fluoroquinolones, with broad-spectrum activity against carbapenem-resistant pathogens

Sulopenem - An orally available β-lactam particularly important for outpatient or mass casualty scenarios, with demonstrated protective effects against plague and anthrax

These agents represent both refinements of existing antibiotic classes and novel mechanisms of action that may overcome resistance.

SECTION 4: Clinical Case Spotlight

The Mystery of the Belgian Malinois: When Bone Swelling Tells a Devastating Story

Meet Josie, a 2-year-old spayed Belgian Malinois who presented for significant lameness on the right hind limb. Josie embodied everything characteristic of her breed incredibly active, high-energy, with that classic drive that makes Malinois exceptional working dogs. She would chase a ball until she physically couldn't get up anymore.

What Josie wasn't great at was resting. Her owner reported worsening bouts of intermittent lameness, as well as an area of swelling on the right hind limb that seemed to come and go since she was about 1 year of age. At a previous appointment, the lameness wasn't as significant, and a soft tissue injury was presumed. There was no reason to consider a more sinister diagnosis at her age.

The Clinical Examination

Physical exam revealed significant clinic anxiety, a toe-touching lameness in the right hind limb, and an obvious asymmetry between her distal tibias. Her right distal tibia was noticeably thicker than her left, but the "swelling" was certainly not soft tissue it felt extremely firm and palpated like bone.

There was no obvious associated subcutaneous edema, no obvious external wound, and the hock maintained a normal range of motion. Josie was already quite stressed and now clearly in pain during examination of the distal right tibia.

Sedation was necessary for radiographs. Under sedation with butorphanol and dexmedetomidine, her rectal temperature was initially 105°F, but came down to 103°F by the time sedation was reversed.

The Devastating Diagnosis

What the radiographs revealed made hearts sink: an aggressive bone lesion, with proliferative cortical/periosteal changes. The radiographic appearance was consistent with osteosarcoma the most common primary bone tumor in dogs, and one that carries a grave prognosis.

Osteosarcoma predominantly affects large and giant breed dogs, with the appendicular skeleton (limbs) involved in approximately 75% of cases. The distal radius and proximal humerus are the most common sites, but any bone can be affected. Median age at diagnosis is typically 7-10 years, making Josie's age of 2 years particularly unusual and heartbreaking.

The Clinical Dilemma

At 2 years of age, Josie faced a devastating diagnosis that would require aggressive treatment: amputation of the affected limb followed by chemotherapy. Even with aggressive treatment, median survival time for appendicular osteosarcoma is approximately 10-12 months, with only 10-15% of dogs surviving beyond two years.

The case highlights several critical clinical lessons:

Age isn't always protective: While osteosarcoma typically affects older dogs, young dogs can develop aggressive bone tumors that behave similarly or even more aggressively

Persistent lameness warrants investigation: Josie's intermittent lameness that worsened over time should have prompted earlier advanced imaging, though hindsight is always clearer

Bone pain differs from soft tissue pain: The firm, bony swelling that waxed and waned represented periosteal new bone formation a hallmark of aggressive bone pathology

High-energy breeds may mask severity: Josie's drive to continue playing despite pain delayed recognition of how serious her condition had become

This case serves as a sobering reminder that not all lameness in young, active dogs represents simple soft tissue injuries or growing pains. Veterinarians must maintain high indices of suspicion for more serious pathology when clinical signs persist or progress despite conservative management.

SECTION 5: The Human Element

Vesicular Cutaneous Lupus: When Specialists Make All the Difference

Duncan, a 10-year-old, 76-pound collie, had itchy, bloody skin lesions for two years. "He had been having what we thought were hot spots, like dogs get sometimes," said Lori Eggleston, Duncan's owner. "We'd clear them up, and they would come back and then we'd have to clear them up again. And our vet said, 'We've done everything we know, you need to take him to Virginia Tech'".

The veterinary dermatology team at Virginia Tech's Veterinary Teaching Hospital examined Duncan, who had a previous diagnosis of erythema multiforme an immune-mediated skin condition causing skin ulcers.

The Specialist's Insight

But Dr. Ivan Ravera, clinical assistant professor of veterinary dermatology, suspected there might be something else going on with Duncan and voiced his concern to colleague Dr. Ben Tham.

"This species is predisposed to have a subtype of lupus that affects the skin, which is the vesicular form," Ravera said. "So I say, 'You know what? You probably have seen more cases than me, but this might be this vesicular subtype of lupus.' And he told me, 'I think you're right'".

A new biopsy confirmed Ravera's suspicion: Duncan was diagnosed with vesicular cutaneous lupus erythematosus a rare autoimmune disease characterized by erosions and ulcerations on the skin, often around the abdomen, groin, and inner ear.

The Treatment Journey

"The immune system is attacking his cells, so you need to suppress that immune response," Ravera explained. "We try with different drugs until we get a maintenance dose. Last time he came in, he was not 100 percent recovered, so we added a topical drug so we can attack both from the inside and from the outside. And now he's looking terrific".

The Egglestons are pleased with their dog's progress and his newfound comfort. "It's been a little slow, but he's gotten better slowly," said Lori Eggleston. "Finally, today, we've gotten where he doesn't have any more open sores, and he's more comfortable".

This case exemplifies several critical aspects of compassionate veterinary care:

The power of referral: Duncan's primary veterinarian recognized when the case exceeded their expertise and made the appropriate referral an act of professional humility that ultimately saved Duncan's quality of life

Collaborative diagnosis: Two specialists working together, with the younger colleague proposing an alternative diagnosis and the senior colleague validating the insight demonstrating that great medicine requires teamwork and openness to different perspectives

Persistent optimization: When initial treatment didn't fully resolve Duncan's condition, the team added topical therapy to attack the problem from multiple angles illustrating that good medicine often requires iterative refinement

Owner partnership: The Egglestons remained committed through a slow improvement process, trusting the specialists and maintaining treatment protocols even when progress seemed gradual

The relationship at the heart of care: Throughout Duncan's journey, what shines through is the genuine care and investment from all parties the referring veterinarian who knew when to seek help, the specialists who approached the case with curiosity and expertise, and the owners who remained dedicated to their dog's wellbeing.

The Claudia Mystery: When a Blue Haze Led to Diagnostic Creativity

Claudia, a one-year-old mixed breed dog transferred to Capital Area Humane Society as a stray, developed a puzzling ocular condition. Shortly after placement, Claudia's foster noticed bilateral eyelid swelling after spending extended time outdoors. Allergies were suspected, so diphenhydramine was prescribed, however over a few days Claudia's eyes became clouded and painful.

The shelter veterinary team examined Claudia and noted a "blue haze" that appeared to wax and wane throughout the day. Her left eye was particularly severe, with a cornea hazy enough to obscure the view into the iris. She was given oral pain medications.

The Diagnostic Process

Because of the cloudy appearance, the team suspected acute glaucoma in the left eye, possibly developing in the right. They procured a tonometer to measure intraocular pressure (IOP), with readings of 12, 16, 12, 11, 10 mmHg in the left eye and 20, 20, 21, 19, 22 mmHg in the right.

These readings were not consistent with glaucoma dogs presenting with this condition usually have readings greater than 25, beyond 40 in severe cases, and even up to the 80s. Claudia was also unusually young for a dog with primary glaucoma. Secondary glaucoma was still possible, but due to severe corneal clouding, they were unable to examine inside her eyes to investigate underlying ocular causes.

This case demonstrates the challenges faced by shelter veterinary teams:

Limited resources requiring creative problem-solving: The team procured a tonometer specifically for Claudia's case, showing commitment to thorough diagnostics despite shelter resource constraints

Young age complicating differential diagnoses: Many classic diseases present in older animals, making diagnosis in young patients particularly challenging

The waxing and waning nature creating diagnostic uncertainty and requiring repeated examinations

Pain management as priority: Even while pursuing diagnosis, the team ensured Claudia received appropriate analgesia demonstrating that compassionate care never waits for a definitive diagnosis

The Broader Message: Compassion Connects All Frontiers

These cases from global humanitarian missions bringing veterinary care to underserved communities, to cutting-edge AI predicting feline kidney disease before symptoms appear, to novel pharmaceuticals offering alternatives to traditional antibiotics, to complex clinical cases requiring specialist collaboration all share a common thread: the human element.

Technology amplifies our capabilities. Innovation extends our reach. But compassion remains the heart of veterinary medicine, whether expressed through a volunteer veterinarian vaccinating street dogs in Nepal, a dermatologist taking time to reconsider a diagnosis, or a shelter team procuring specialized equipment for a stray dog with mysterious eye disease.

The profession's many frontiers ultimately converge in the exam room, where veterinarian and client partner in caring for an animal who cannot speak for themselves. That sacred trust that shared commitment to animal welfare defines us more than any technology, medication, or diagnostic tool ever could.

Conclusion: One Profession, Infinite Possibilities

The veterinary profession in 2025 operates simultaneously on global, technological, pharmaceutical, clinical, and humanitarian frontiers. The WVA's strategic plan unifies 7 million veterinarians worldwide. AI achieves 95% diagnostic accuracy. Novel medications offer hope beyond traditional antibiotics. Complex cases find solutions through specialist collaboration. And throughout it all, compassion remains our guiding principle.

Whether practicing in a high-tech specialty hospital with the latest AI-powered imaging or working in a remote village with basic supplies and boundless dedication, veterinarians share a common purpose: using knowledge, skill, and compassion to improve animal health and welfare.

The frontiers are many.

The challenges are real. The opportunities are extraordinary. But the heart of the profession remains unchanged: veterinarians caring for animals and serving the humans who love them.

One profession. Many frontiers. Infinite possibilities.

Ready to Join the Global Community?

Discover how VettConsult connects you to the latest innovations, research, and collaborative networks shaping veterinary medicine's many frontiers.